Since January of 2016, patients have been able to legally obtain medical cannabinoids in New York. According to the New York Department of Health, Physicians certified over 5,000 patients in the first six months of the medical cannabinoids Program.

Do you Qualify for medical cannabinoids?

To qualify for medical cannabinoids in New York, patients need to meet certain criteria as laid out in New York’s Compassionate Care Act. The conditions that qualify include Neuropathy, Cancer, Inflammatory Bowel Disease (IBD), HIV/AIDS and several other neurological conditions, including Epilepsy, Parkinson’s, Multiple Sclerosis, Spinal Cord Injury, ALS and Huntington’s Disease. The related symptoms listed are pain, spasticity, nausea, weight loss (medically speaking “Cachexia”) and seizures. The NYS Department of Health can also add additional conditions. Chronic pain and PTSD are currently under consideration.

Additional medical cannabinoids Requirements in NY

  • Live in New York and have a valid New York State Driver’s License or New York State Identification.
  • Receive treatment in New York for the qualifying disease and symptom.
  • Evaluation from a New York physician who has registered with New York State Department of Health to authorize patients for medical cannabinoids.

Steps to Obtain medical cannabinoids in New York

New Yorkers who want to be treated with medical cannabinoids should first see a physician registered with NYS DOH. If the physician feels that you might benefit from treatment, they will certify you and you can then apply for a medical cannabinoids card online. The card is sent by mail and usually arrives within 1-2 weeks. You can take the card, along with the certification document, to any dispensary and receive medical cannabinoids for treatment.

Michael Morgenstern, MD

Michael Morgenstern, MD

Founder at NY Medical Marijuana Association
About the author: Dr. Michael Morgenstern is double board certified in Neurology and Sleep Medicine. He works in private practice in Manhattan, Queens and Long Island and has extensive expertise treating patients with Medical Cannabinoids.
Michael Morgenstern, MD

Latest posts by Michael Morgenstern, MD (see all)